Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes
Background: There is high demand for blood biomarkers that reflect the therapeutic response or predict the outcomes of patients with acute ischemic stroke (AIS); however, few biomarkers have been evidentially verified to date. This study evaluated two proteins, oxidized albumin (OxHSA) and cartilage...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8475af34b3a4606a9e01335ff366cc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e8475af34b3a4606a9e01335ff366cc8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e8475af34b3a4606a9e01335ff366cc82021-12-01T20:31:59ZOxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes1664-229510.3389/fneur.2021.686555https://doaj.org/article/e8475af34b3a4606a9e01335ff366cc82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.686555/fullhttps://doaj.org/toc/1664-2295Background: There is high demand for blood biomarkers that reflect the therapeutic response or predict the outcomes of patients with acute ischemic stroke (AIS); however, few biomarkers have been evidentially verified to date. This study evaluated two proteins, oxidized albumin (OxHSA) and cartilage acidic protein-1 (CRTAC1), as potential prognostic markers of AIS.Methods: The ratio of OxHSA to normal albumin (%OxHSA) and the level of CRTAC1 in the sera of 74 AIS patients were analyzed on admission (day 0), and at 1 and 7 days after admission. AIS patients were divided into two groups according to their modified Rankin Scale (mRS) at 3 months after discharge: the low-mRS (mRS < 2) group included 48 patients and the high-mRS (mRS ≥ 2) group included 26 patients. The differences in %OxHSA and CRTAC1 between the two groups on days 0, 1, and 7 were evaluated.Results: The mean %OxHSA values of the high-mRS group on days 0, 1, and 7 were significantly higher than those of the low-mRS group (p < 0.05). The CRTAC1 levels continuously increased from day 0 to day 7, and those of the high-mRS group were significantly higher than those of the low-mRS group on day 7 (p < 0.05).Conclusions: These results suggest that higher %OxHSA and CRTAC1 are associated with poor outcomes in AIS patients. An index that combines %OxHSA and CRTAC1 can accurately predict the outcomes of AIS patients.Takahiro KuwashiroKazuhiro TanabeKazuhiro TanabeChihiro HayashiTadataka MizoguchiKota MoriJuro JinnouchiMasahiro YasakaYasushi OkadaFrontiers Media S.A.articleacute ischemic strokecartilage acidic protein-1oxidative stressoxidized albuminmass spectrometryLC-MS/MSNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
acute ischemic stroke cartilage acidic protein-1 oxidative stress oxidized albumin mass spectrometry LC-MS/MS Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
acute ischemic stroke cartilage acidic protein-1 oxidative stress oxidized albumin mass spectrometry LC-MS/MS Neurology. Diseases of the nervous system RC346-429 Takahiro Kuwashiro Kazuhiro Tanabe Kazuhiro Tanabe Chihiro Hayashi Tadataka Mizoguchi Kota Mori Juro Jinnouchi Masahiro Yasaka Yasushi Okada Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
description |
Background: There is high demand for blood biomarkers that reflect the therapeutic response or predict the outcomes of patients with acute ischemic stroke (AIS); however, few biomarkers have been evidentially verified to date. This study evaluated two proteins, oxidized albumin (OxHSA) and cartilage acidic protein-1 (CRTAC1), as potential prognostic markers of AIS.Methods: The ratio of OxHSA to normal albumin (%OxHSA) and the level of CRTAC1 in the sera of 74 AIS patients were analyzed on admission (day 0), and at 1 and 7 days after admission. AIS patients were divided into two groups according to their modified Rankin Scale (mRS) at 3 months after discharge: the low-mRS (mRS < 2) group included 48 patients and the high-mRS (mRS ≥ 2) group included 26 patients. The differences in %OxHSA and CRTAC1 between the two groups on days 0, 1, and 7 were evaluated.Results: The mean %OxHSA values of the high-mRS group on days 0, 1, and 7 were significantly higher than those of the low-mRS group (p < 0.05). The CRTAC1 levels continuously increased from day 0 to day 7, and those of the high-mRS group were significantly higher than those of the low-mRS group on day 7 (p < 0.05).Conclusions: These results suggest that higher %OxHSA and CRTAC1 are associated with poor outcomes in AIS patients. An index that combines %OxHSA and CRTAC1 can accurately predict the outcomes of AIS patients. |
format |
article |
author |
Takahiro Kuwashiro Kazuhiro Tanabe Kazuhiro Tanabe Chihiro Hayashi Tadataka Mizoguchi Kota Mori Juro Jinnouchi Masahiro Yasaka Yasushi Okada |
author_facet |
Takahiro Kuwashiro Kazuhiro Tanabe Kazuhiro Tanabe Chihiro Hayashi Tadataka Mizoguchi Kota Mori Juro Jinnouchi Masahiro Yasaka Yasushi Okada |
author_sort |
Takahiro Kuwashiro |
title |
Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
title_short |
Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
title_full |
Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
title_fullStr |
Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
title_full_unstemmed |
Oxidized Albumin and Cartilage Acidic Protein-1 as Blood Biomarkers to Predict Ischemic Stroke Outcomes |
title_sort |
oxidized albumin and cartilage acidic protein-1 as blood biomarkers to predict ischemic stroke outcomes |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/e8475af34b3a4606a9e01335ff366cc8 |
work_keys_str_mv |
AT takahirokuwashiro oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT kazuhirotanabe oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT kazuhirotanabe oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT chihirohayashi oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT tadatakamizoguchi oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT kotamori oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT jurojinnouchi oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT masahiroyasaka oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes AT yasushiokada oxidizedalbuminandcartilageacidicprotein1asbloodbiomarkerstopredictischemicstrokeoutcomes |
_version_ |
1718404606759796736 |